Provided by Tiger Trade Technology Pte. Ltd.

VIVA BIOTECH

1.590
+0.0100.63%
Volume:4.96M
Turnover:7.73M
Market Cap:3.33B
PE:17.67
High:1.600
Open:1.560
Low:1.520
Close:1.580
52wk High:3.270
52wk Low:1.040
Shares:2.09B
HK Float Shares:2.09B
Volume Ratio:0.68
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.090
ROE:6.88%
ROA:1.70%
PB:0.71
PE(LYR):17.67
PS:1.65

Loading ...

Viva Biotech repurchases 0.96 million shares; May buy-backs climb to 10.20 million, 0.48% of share capital

Bulletin Express
·
May 15

VIVA BIOTECH Executes Share Buyback on May 15

Stock News
·
May 15

VIVA Biotech files HKEX next-day return disclosing share buyback at HKD 1.45/share

Reuters
·
May 15

Viva Biotech executes fourth consecutive buyback; 1.60 million shares repurchased on 13 May, cumulative May purchases reach 8.48 million shares

Bulletin Express
·
May 13

VIVA BIOTECH (01873) Repurchases 1.6 Million Shares for HK$2.414 Million on May 13

Stock News
·
May 13

VIVA Biotech files HKEX next-day return, discloses share buyback at HKD 1.51

Reuters
·
May 13

VIVA BIOTECH Announces Share Buyback Transaction on May 12

Stock News
·
May 12

VIVA Biotech files HKEX next-day return, discloses share buyback at HKD 1.57 each

Reuters
·
May 12

VIVA BIOTECH (01873) Invests HK$6.47 Million in Share Buyback on May 8

Stock News
·
May 11

VIVA Biotech files HKEX return, repurchases shares at HKD 1.55 each

Reuters
·
May 11

VIVA BIOTECH (01873) Repurchases 4.164 Million Shares for HK$6.4714 Million on May 8

Stock News
·
May 08

VIVA Biotech files HKEX return, repurchases shares at HKD 1.55 each

Reuters
·
May 08

Viva Biotech Reports Stable Share Capital and Public Float Compliance for April 2026

Bulletin Express
·
May 07

Viva Biotech Holdings' (HKG:1873) Profits May Not Reveal Underlying Issues

Simply Wall St.
·
Apr 30

VIVA BIOTECH's Shares Nearly Halved in Three Months, Lagging Behind CXO Sector's Rebound

Stock News
·
Apr 27

VIVA BIOTECH 2025 ESG Report: Net Profit Up 21.30%, Carbon Emissions Cut 6%, AI-Driven Drug Discovery Unveiled

Bulletin Express
·
Apr 22

维亚生物2025年净利同比增至人民币2.693亿元,CRO与CDMO业务双线发力

Bulletin Express
·
Apr 22

Viva Biotech calls 26 June 2026 AGM; proposes 20 % share-issue mandate, 10 % buy-back limit and re-election of three directors

Bulletin Express
·
Apr 22

VIVA Biotech Holdings announces annual general meeting

Reuters
·
Apr 22

Viva Biotech publishes 2025 annual report

Reuters
·
Apr 22